The FDA was putting out what's called a black box warning before she registered as a lobbyist
SupportedKelly Ayotte, at New Hampshire Governor General Election Debate (WMUR)
7:42 pmWhy this verdict View evidenceHide evidence
Why we checked itSpecific claim about FDA regulatory action (black box warning) and its timing relative to when an opponent registered as a lobbyist — verifiable against FDA records and lobbying registration dates
What we foundThe FDA issued a black box warning for OxyContin in July 2001, and state records confirm Warmington registered as a Purdue Pharma lobbyist in December 2001 — making the black box warning predated her registration by approximately five months.